Category: piperidines

Application of 88495-54-9, As an important bridge between the micro and macro material world, chemistry is one of the main methods and means for humans to understand and transform the material world. 88495-54-9, Name is (S)-1-(tert-Butoxycarbonyl)piperidine-3-carboxylic acid, SMILES is O=C([C@@H]1CN(C(OC(C)(C)C)=O)CCC1)O, belongs to piperidines compound. In a article, author is Celik, Ismail, introduce new discover of the category.

Evaluation of Activity of Some 2,5-Disubstituted Benzoxazole Derivatives against Acetylcholinesterase, Butyrylcholinesterase and Tyrosinase: ADME Prediction, DFT and Comparative Molecular Docking Studies

In this study, p-tert-butyl at position 2 and acetamide bridged 4-substituted piperazine/piperidine at position 5 bearing benzoxazole derivatives were evaluated for their in vitro inhibitory activity against AChE, BChE and Tyrosinase, which are important targets in reducing the adverse effects of Alzheimer’s disease. The most active 1 g inhibited the BChE at a concentration of 50 mu M by 54 +/- 0.75%. Molecular docking studies of the compounds against BChE (PDB: 4BDS) were performed with Schrodinger and AutoDock Vina and the results were compared. Schrodinger docking scores were found to be more consistent. Estimated ADME profiles and bioactivity scores of the compounds were calculated and found to be compatible with Lipinski and other limiting rules. Geometric optimization parameters, MEP analysis and HUMO and LUMO quantum parameters of the most active 1 g were calculated by using DFT/B3LYP theory and 6-311 G (d,p) base set and results was viewed.

Application of 88495-54-9, Consequently, the presence of a catalyst will permit a system to reach equilibrium more quickly, but it has no effect on the position of the equilibrium as reflected in the value of its equilibrium constant.I hope my blog about 88495-54-9 is helpful to your research.

Reference:
Piperidine – Wikipedia,
,Piperidine | C5H11N – PubChem

 

Reactions catalyzed within inorganic and organic materials and at electrochemical interfaces commonly occur at high coverage and in condensed media, causing turnover rates to depend strongly on interfacial structure and composition, 124172-53-8, Name is N,N’-(Hexane-1,6-diyl)bis(N-(2,2,6,6-tetramethylpiperidin-4-yl)formamide), SMILES is O=CN(CCCCCCN(C1CC(C)(C)NC(C)(C)C1)C=O)C2CC(C)(C)NC(C)(C)C2, in an article , author is Fatahpour, Maryam, once mentioned of 124172-53-8, Recommanded Product: 124172-53-8.

One-pot multicomponent synthesis of piperidinium 3,3 ‘-(arylmethylene) bis (2-hydroxynaphthalene-1,4-diones): NMR spectroscopic and X-ray structure characterization

A facile synthesis of piperidinium 3,3’-(arylmethylene) bis (2-hydroxynaphthalene-1,4-dione) analogs as organic salts is described by the one-pot pseudo-four-component reaction between 2-hydroxy-1,4-naphthoquinone, aromatic aldehydes, and piperidine. The single-crystal X-ray diffraction analysis of these systems confirms that the stabilized predominant interactions are N-H center dot center dot center dot O and O-H center dot center dot center dot O hydrogen bonds. Mild and clean reaction conditions, high atom economy, and operational simplicity of this one-pot multicomponent reaction coupled with excellent yields and no need for column chromatography have transformed this procedure to be a superior synthetic route for the efficient formation of families of naphthoquinone-derived compounds.

Interested yet? Read on for other articles about 124172-53-8, you can contact me at any time and look forward to more communication. Recommanded Product: 124172-53-8.

Reference:
Piperidine – Wikipedia,
,Piperidine | C5H11N – PubChem

 

In an article, author is Strey, Mark, once mentioned the application of 108-26-9, Computed Properties of C4H6N2O, Name is 3-Methyl-1H-pyrazol-5(4H)-one, molecular formula is C4H6N2O, molecular weight is 98.1, MDL number is MFCD00020699, category is piperidines. Now introduce a scientific discovery about this category.

Amine complexes of gold, part 10: gold(I) thiocyanate complexes with tetrahydrothiophene, dimethyl sulfide, ammonia, amines and azaaromatics

The reaction of (tht) AuCl (tht = tetrahydrothiophene) with KSCN leads to a mixture of gold(I) thiocyanate AuSCN and [(tht)(2)Au](+) [Au(SCN)(2)](-) 1. The compounds were separated and the X-ray structure of 1 confirmed as an alternating chain of anions and cations linked by aurophilic contacts. Either pure AuSCN or the mixture was used to synthesize further derivatives of AuSCN, all of which were investigated by X-ray methods. Most products were of limited stability when removed from their mother liquor. The dimethyl sulfide derivative 2 is molecular, (Me2S) AuSCN; the ammonia derivative 3 is ionic, [(NH3)(2)Au](+) [Au(SCN)(2)](-). The reaction with 2,2-bipyridyl leads (presumably by involvement of the solvent or of atmospheric moisture) to [bipy-H](+) [Au(SCN)(2)](-) 13. All other products involve amines or azaaromatics as ligands L. The primary amine tert-butylamine forms an ionic product [L2Au](+) (SCN)(-) 4. The secondary amines piperidine and dibenzylamine lead to molecular structures LAuSCN (5 and 6), whereas pyridine-based azaaromatics lead to ionic products [L2Au](+) [Au(SCN)(2)](-) with L = 2-, 3- or 4-picoline (7-9), 2,4-, 3,4- or 3,5-lutidine (10-12). The 3,4-lutidine derivative 11 forms two polymorphs that tend to form mixed crystals. The dominant features of the crystal packing for 7-12 are short aurophilic interactions.

If you are interested in 108-26-9, you can contact me at any time and look forward to more communication. Computed Properties of C4H6N2O.

Reference:
Piperidine – Wikipedia,
,Piperidine | C5H11N – PubChem

 

In an article, author is Minamimoto, Ryogo, once mentioned the application of 622-26-4, Name is 2-(Piperidin-4-yl)ethanol, molecular formula is C7H15NO, molecular weight is 129.2001, MDL number is MFCD00006008, category is piperidines. Now introduce a scientific discovery about this category, Product Details of 622-26-4.

Prospective Evaluation of Ga-68-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging

Ga-68-labeled DOTA-4-amino-1-carboxymethyl-piperidine-D-Phe-GlnTrp- Ala-Val-Gly-His-Sta-Leu-NH2 (Ga-68-RM2) is a synthetic bombesin receptor antagonist that targets gastrin-releasing peptide receptor (GRPr). GRPr proteins are highly overexpressed in several human tumors, including prostate cancer (PCa). We present data from the use of Ga-68-RM2 in patients with biochemical recurrence (BCR) of PCa and negative findings on conventional imaging. Methods: We enrolled 32 men with BCR of PCa, who were 59-83 y old (mean +/- SD, 68.7 +/- 6.4 y). Imaging started at 40-69 min (mean, 50.5 +/- 6.8 min) after injection of 133.2-151.7 MBq (mean, 140.6 +/- 7.4 MBq) of (68)GaRM2 using a time-of-flight-enabled simultaneous PET/MRI scanner. T1-weighted, T2-weighted, and diffusion-weighted images were acquired. Results: All patients had a rising level of prostate-specific antigen (PSA) (range, 0.3-119.0 ng/mL; mean, 10.1 +/- 21.3 ng/mL) and negative findings on conventional imaging (CT or MRI, and a Tc-99m-methylene diphosphonate bone scan) before enrollment. The observed Ga-68-RM2 PET detection rate was 71.8%. Ga-68-RM2 PET identified recurrent PCa in 23 of the 32 participants, whereas the simultaneous MRI scan identified findings compatible with recurrent PCa in 11 of the 32 patients. PSA velocity was 0.32 +/- 0.59 ng/mL/y (range, 0.04-1.9 ng/mL/y) in patients with negative PET findings and 2.51 +/- 2.16 ng/mL/y (range, 0.13-8.68 ng/mL/y) in patients with positive PET findings (P 5 0.006). Conclusion: Ga-68-RM2 PET can be used for assessment of GRPr expression in patients with BCR of PCa. High uptake in multiple areas compatible with cancer lesions suggests that Ga-68-RM2 is a promising PET radiopharmaceutical for localization of disease in patients with BCR of PCa and negative findings on conventional imaging.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 622-26-4, Product Details of 622-26-4.

Reference:
Piperidine – Wikipedia,
,Piperidine | C5H11N – PubChem

 

In an article, author is Peschiulli, Aldo, once mentioned the application of 120-73-0, Name: Purine, Name is Purine, molecular formula is C5H4N4, molecular weight is 120.11, MDL number is MFCD00079221, category is piperidines. Now introduce a scientific discovery about this category.

3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: Potent and permeable BACE-1 inhibitors

Since its discovery in 1999, BACE-1, a membrane anchored aspartyl protease expressed primarily in the CNS, has been the target of numerous medicinal chemistry research programs. These efforts have produced highly potent inhibitors with nanomolar affinity and ever-increasing structural complexity. However, only a handful of these molecules have been able to combine in vitro potency with CNS permeability and progressed to the clinic. Herein, we describe a set of novel piperidine-based inhibitors. This investigation culminated with the identification of 43, a highly potent (IC50 : 1.5 nM), permeable BACE-1 inhibitor with a low susceptibility to Pgp-mediated efflux.

If you are interested in 120-73-0, you can contact me at any time and look forward to more communication. Name: Purine.

Reference:
Piperidine – Wikipedia,
,Piperidine | C5H11N – PubChem

 

Catalysts are substances that increase the reaction rate of a chemical reaction without being consumed in the process. 120013-39-0, Name is 5,6-Dimethoxy-2-(4-piperidinylmethyl)-1-indanone hydrochloride, SMILES is Cl.COC2=C(C=C1C(C(CC1=C2)CC3CCNCC3)=O)OC, belongs to piperidines compound. In a document, author is Sowa, Alexandra R., introduce the new discover, Safety of 5,6-Dimethoxy-2-(4-piperidinylmethyl)-1-indanone hydrochloride.

Development of Positron Emission Tomography Radiotracers for the GABA Transporter 1

In vivo positron emission tomography (PET) imaging of the gamma-aminobutyric acid (GABA) receptor complex has been accomplished using radiolabeled benzodiazepine derivatives, but development of specific presynaptic radio-ligands targeting the neuronal membrane GABA transporter type 1 (GAT-1) has been less successful. The availability of new structure-activity studies of GAT-1 inhibitors and the introduction of a GAT-1 inhibitor (tiagabine, Gabatril) into clinical use prompted us to reinvestigate the syntheses of PET ligands for this transporter. Initial synthesis and rodent PET studies of N-[C-11]methylnipecotic acid confirmed the low brain uptake of that small and polar molecule. The common design approach to improve blood-brain barrier permeability of GAT-1 inhibitors is the attachment of a large lipophilic substituent. We selected an unsymmetrical bis-aromatic residue attached to the ring nitrogen by a vinyl ether spacer from a series recently reported by Wanner and coworkers. Nucleophilic aromatic substitution of an aryl chloride precursor with [F-18]fluoride was used to prepare the desired candidate radiotracer (R,E/Z)-1-(2-((4-fluoro-2-(4-[F-18](-)uorobenzoyl)styryl)oxy)ethyl)-piperidine-3-carboxylic acid ((R,E/Z)-[F-18]10). PET studies in rats showed no brain uptake, which was not altered by pretreatment of animals with the P-glycoprotein inhibitor cyclosporine A, indicating efflux by Pgp was not responsible. Subsequent PET imaging studies of (R,E/Z)-[F-18]10 in rhesus monkey brain showed very low brain uptake. Finally, to test if the free carboxylic acid group was the likely cause of poor brain uptake, PET studies were done using the ethyl ester derivative of (R,E/Z)-[F-18]10. Rapid and significant monkey brain uptake of the ester was observed, followed by a slow washout over 90 min. The blood-brain barrier permeability of the ester supports a hypothesis that the free acid function limits brain uptake of nipecotic acid-based GAT-1 radioligands, and future radiotracer efforts should investigate the use of carboxylic acid bioisosteres.

The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 120013-39-0 is helpful to your research. Safety of 5,6-Dimethoxy-2-(4-piperidinylmethyl)-1-indanone hydrochloride.

Reference:
Piperidine – Wikipedia,
,Piperidine | C5H11N – PubChem

 

In an article, author is Harkiss, Alexander H., once mentioned the application of 41661-47-6, Name is Piperidin-4-one, molecular formula is C5H9NO, molecular weight is 99.1311, MDL number is MFCD00955709, category is piperidines. Now introduce a scientific discovery about this category, Recommanded Product: 41661-47-6.

Access to 2,6-Disubstituted 4-Oxopiperidines Using a 6-Endo-trig Cyclization: Stereoselective Synthesis of Spruce Alkaloid and (+)-241 D

A synthetic route to cis-2-methyl-4-oxo-6-alkylpiperidines has been developed using a 6-endo-trig cyclization of (E)-enones. The base-mediated intramolecular cyclization was found to be general for both alkyl- and aryl-substituted enones, providing the corresponding 4-oxopiperidines in high yields (8089%). Stereoselective reduction of the 2,6-cis-disubstituted 4-oxopiperidines then gave the 2,4,6-cis,cis-trisubstituted 4-hydroxypiperidines in high diastereoselectivity. The general nature of this approach was demonstrated with the synthesis of the natural products, spruce alkaloid and (+)-241D.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 41661-47-6, Recommanded Product: 41661-47-6.

Reference:
Piperidine – Wikipedia,
,Piperidine | C5H11N – PubChem

 

Chemistry can be defined as the study of matter and the changes it undergoes. You’ll sometimes hear it called the central science because it is the connection between physics and all the other sciences, starting with biology. 41556-26-7, Name is Bis(1,2,2,6,6-pentamethylpiperidin-4-yl) decanedioate, molecular formula is , belongs to piperidines compound. In a document, author is Kiso, Tetsuo, Product Details of 41556-26-7.

ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain

Exogenous cannabinoid receptor agonists are clinically effective for treating chronic pain but frequently cause side effects in the central nervous system. Fatty acid amide hydrolase (FAAH) is a primary catabolic enzyme for anandamide, an endogenous cannabinoid agonist. 3-Pyridyl 4-(phenylcarbamoyl)piperidine-1-carboxylate (ASP8477) is a potent and selective FAAH inhibitor that is orally active and able to increase the brain anandamide level and is effective in rat models of neuropathic and osteoarthritis pain without causing motor coordination deficits. In the present study, we examined the pharmacokinetics and pharmacodynamics, analgesic spectrum in pain models, and the anti-nociceptive mechanism of ASP8477. Single and four-week repeated oral administration of ASP8477 ameliorated mechanical allodynia in spinal nerve ligation rats with similar improvement rates. Further, single oral administration of ASP8477 improved thermal hyperalgesia and cold allodynia in chronic constriction nerve injury rats. ASP8477 also restored muscle pressure thresholds in reserpine-induced myalgia rats. This analgesic effect of ASP8477 persisted for at least 4 h, consistent with the inhibitory effect observed in an ex vivo study using rat brain as well as the increasing effect on oleoylethanolamide and palmitoylethanolamide levels but not the ASP8477 concentration in rat brain. ASP8477 also improved alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-, N-methyl-D-aspartic acid (NMDA)-, prostaglandin E-2-, prostaglandin F-2(alpha)-, and bicuculline-induced allodynia in mice, showing broader analgesic spectra than existing drugs. In contrast, however, ASP8477 did not affect acute pain. These results indicate that the FAAH inhibitor ASP8477 exerts analgesic effects on neuropathic and dysfunctional pain, and its pharmacological properties are suitable for use in treating chronic pain.

Sometimes chemists are able to propose two or more mechanisms that are consistent with the available data. If a proposed mechanism predicts the wrong experimental rate law, however, the mechanism must be incorrect.Welcome to check out more blogs about 41556-26-7, in my other articles. Product Details of 41556-26-7.

Reference:
Piperidine – Wikipedia,
,Piperidine | C5H11N – PubChem

 

The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature. 5570-77-4, Name is 4-Chloro-1-methylpiperidine, SMILES is CN1CCC(CC1)Cl, in an article , author is Kang, Dongwei, once mentioned of 5570-77-4, Recommanded Product: 4-Chloro-1-methylpiperidine.

Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties

The development of efficacious NNRTIs for AIDS therapy commonly encountered the rapid generation of drug-resistant mutations, which becomes a major impediment to effective anti-HIV treatment. Using a structure-based bioisosterism strategy, a series of piperidine-substituted thiophene[2,3-d]pyrimidine derivatives were designed and synthesized. Compound 9a yielded the greatest potency, exhibiting significantly better anti-HIV-1 activity than ETR against all of the tested NNRTI-resistant HIV-1 strains. In addition, the phenotypic (cross)resistance of 9a and other NRTIs to the different selected HIV-1 strains was evaluated. As expected, no phenotypic cross-resistance against the NRTIs (AZT and PMPA) was observed with the mutant 9a(res) strain. Furthermore, 9a was identified with improved solubility, lower CYP liability, and hERG inhibition. Remarkably, 9a exhibited optimal pharmacokinetic properties in rats (F = 37.06%) and safety in mice (LD50 > 2000 mg/kg), which highlights 9a as a promising anti-HIV-1 drug candidate.

Interested yet? Read on for other articles about 5570-77-4, you can contact me at any time and look forward to more communication. Recommanded Product: 4-Chloro-1-methylpiperidine.

Reference:
Piperidine – Wikipedia,
,Piperidine | C5H11N – PubChem

 

In an article, author is Vernon, Samuel W., once mentioned the application of 10465-81-3, Quality Control of Diazene-1,2-diylbis(piperidin-1-ylmethanone), Name is Diazene-1,2-diylbis(piperidin-1-ylmethanone), molecular formula is C12H20N4O2, molecular weight is 252.3128, MDL number is MFCD00010111, category is piperidines. Now introduce a scientific discovery about this category.

The VAChT(Y49N) mutation provides insecticide-resistance but perturbs evoked cholinergic neurotransmission in Drosophila

Global agriculture and the control of insect disease vectors have developed with a heavy reliance on insecticides. The increasing incidence of resistance, for virtually all insecticides, threatens both food supply and effective control of insect borne disease. CASPP ((5-chloro-1′-[(E)-3-(4-chlorophenyl)allyl]spiro[indoline-3,4′-piperidine]-1-yl}-(2-chloro-4-pyridyl)methanone)) compounds are a potential new class of neuroactive insecticide specifically targeting the Vesicular Acetylcholine Transporter (VAChT). Resistance to CASPP, under laboratory conditions, has been reported following either up-regulation of wildtype VAChT expression or the presence of a specific point mutation (VAChT(Y49N)). However, the underlying mechanism of CASPP-resistance, together with the consequence to insect viability of achieving resistance, is unknown. In this study, we use electrophysiological characterisation of cholinergic release at Drosophila larval interneuron -> motoneuron synapses to investigate the physiological implications of these two identified modes of CASPP resistance. We show that both VAChT up-regulation or the expression of VAChT(Y49N) increases miniature (mini) release frequency. Mini frequency appears deterministic of CASPP activity. However, maintenance of SV release is not indicative of resistance in all cases. This is evidenced through expression of syntaxin or complexin mutants (sytx(3-61)/cpX(SH1)) that show similarly high mini release frequency but are not resistant to CASPP. The VAChT(Y49N) mutation additionally disrupts action potential-evoked cholinergic release and fictive locomotor patterning through depletion of releasable synaptic vesicles. This observation suggests a functional trade-off for this point mutation, which is not seen when wildtype VAChT is up-regulated.

If you are interested in 10465-81-3, you can contact me at any time and look forward to more communication. Quality Control of Diazene-1,2-diylbis(piperidin-1-ylmethanone).

Reference:
Piperidine – Wikipedia,
,Piperidine | C5H11N – PubChem